Related Experiment Video
Updated: May 21, 2026

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Are we ready to implant left ventricular assist devices in "less sick" patients?
1Section of Cardiac and Thoracic Surgery, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois, USA. jeevan@uchicago.edu
Abstract:
Left ventricular assist devices improve survival for New York Heart Association class IV patients as both destination therapy and bridge-to-transplant therapy. This clinical benefit has been demonstrated in multiple clinical trials whose medical comparator arm consists of patients with very poor survival. This article discusses the potential use of left ventricular assist devices in a less sick group of patients with end-stage congestive heart failure.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies

